The CDC’s ACIP recommends newly FDA-approved Shingrix as the preferred vaccine for the prevention of shingles in individuals 50 years of age or older.
Colleen Owens
Advertisement
Articles by Colleen Owens
Advertisement
Latest Updated Articles
ACIP Endorses Shingrix As Preferred Shingles Vaccine for Adults Aged 50 & OlderPublished: October 27th 2017 | Updated:
Advertisement
Advertisement
Trending on Contagion Live
1
Phase 3 Trial Confirms Superior Efficacy of Oral Pritelivir for Refractory HSV in Immunocompromised Patients
2
Higher Acceptability of 1 Injectable in First Head-to-Head Comparison of Long-Acting PrEP
3
Developing the Next Generation of Rifamycins for Non-TB Mycobacteria in a Post-Antibiotic Era
4
